Response to: Challenges to the Possible Use of Bisphosphonates in Early-Stage Osteoarthritis
J Bone Miner Res
.
2021 Apr;36(4):815-816.
doi: 10.1002/jbmr.4232.
Epub 2020 Dec 30.
Authors
Kaleen N Hayes
1
,
Vasily Giannakeas
1
2
,
Andy Kin On Wong
1
3
4
Affiliations
1
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
2
Women's College Hospital, Toronto, Canada.
3
Joint Department of Medical Imaging, University Health Network, Toronto, Canada.
4
Osteoporosis Program, Schroeder Arthritis Institute, University Health Network, Toronto, Canada.
PMID:
33378555
DOI:
10.1002/jbmr.4232
No abstract available
Publication types
Letter
Comment
MeSH terms
Bone Density Conservation Agents*
Diphosphonates / therapeutic use
Humans
Osteoarthritis* / drug therapy
Substances
Bone Density Conservation Agents
Diphosphonates